Angiolutions specializes in device-based innovation in vascular medicine. Through its latest award-winning technology, the company aims to prevent the deadly progression of small abdominal aortic aneurysms.
An abdominal aortic aneurysm is a bulging of the abdominal aorta. With a growing aneurysm diameter, the risk of fatal rupture increases. While this progressive disease affects a substantial number of patients worldwide, there is no therapy available to stop aneurysm growth. Based on latest research findings, that the founding team acquired during its academic work, Angiolutions aims to stop aneurysm progression at an early stage.

Press releases

HTGF Investment Angiolutions

Gründerteam Angiolutions
Angiolutions’ novel vascular implant defuses the abdominal ticking time bomb The award-winning team of the medtech startup Angiolutions successfully secured its seed financing round with High-Tech Gründerfonds, FRIBA Investment and NBank Capital. Based on the founders’…

Info & Contact


Ludwig-Thoma-Strasse 15e
91054 Erlangen

In portfolio

09. Dec 2020